[144] Hims & Hers Health, Inc. SEC Filing

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) Form 144 notice reports a proposed sale of 2,637 Class A shares to be executed through Fidelity Brokerage Services on 09/29/2025 with an aggregate market value of $155,029.23, against 217,641,958 shares outstanding. The filing states those shares were acquired on 09/15/2025 by restricted stock vesting and were paid as compensation.

The filer discloses multiple recent Class A sales by Soleil Boughton during June–September 2025, each around 2,571–2,637 shares, generating gross proceeds reported per trade. The notice includes the standard Rule 144 representation regarding material nonpublic information and is a routine compliance filing for insider sales of vested compensation shares.

Positive

• Compliance disclosure: The filer submitted a Form 144 and provided broker, share count, and market value details consistent with Rule 144 requirements.
• Source of shares: The securities were acquired by restricted stock vesting and paid as compensation, indicating these are employee awards rather than purchased holdings.

Negative

• Recent sales activity: The same individual, Soleil Boughton, executed multiple Class A share sales in June–September 2025, which could be noted by investors though amounts are small relative to total outstanding shares.

Insights

Financial Analyst

TL;DR: Routine insider sale of recently vested shares; not material to market capitalization.

The filing shows a single proposed sale of 2,637 Class A shares valued at $155,029.23 and multiple small sales in the prior three months by the same individual. Relative to the issuer's 217.6 million shares outstanding, these transactions are immaterial to supply or market cap. The acquisition was restricted stock vesting and payment is listed as compensation, indicating these are vested employee shares rather than open-market purchases. From a financial perspective, this is a transparency/compliance action rather than a signal of material corporate change.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 requirements; repeated small sales merit monitoring but are routine.

The form contains required attestations about material nonpublic information and lists the broker and sale schedule. Multiple sales by the same person over several dates are disclosed, consistent with periodic insider liquidity from vested awards. There is no indication of a 10b5-1 plan date or other trading-plan details included in the notice. Governance-wise, the filing meets disclosure norms; absence of additional context (e.g., plan adoption date) is factual and should not be inferred.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2637	155029.23	217641958	09/29/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	09/15/2025	Restricted Stock Vesting	Issuer			2637	09/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/30/2025	2572	129886.00
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/14/2025	2572	122993.04
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/28/2025	2572	150976.40
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	08/11/2025	2572	132818.08
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	08/25/2025	2571	114486.63
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	09/17/2025	2637	133168.50

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the HIMS Form 144 report?

The filing reports a proposed sale of 2,637 Class A shares via Fidelity on 09/29/2025 with an aggregate market value of $155,029.23.

How were the shares acquired that are being sold?

The shares were acquired on 09/15/2025 through restricted stock vesting and the payment type is listed as compensation.

Has the filer sold other HIMS shares recently?

Yes. The filing lists six prior Class A sales by Soleil Boughton on 06/30/2025, 07/14/2025, 07/28/2025, 08/11/2025, 08/25/2025, and 09/17/2025 with gross proceeds reported for each trade.

Are these sales material relative to HIMS outstanding shares?

No. The proposed sale and recent transactions are small relative to the reported 217,641,958 shares outstanding, so they are not material to total share count.

Does the filing indicate the presence of a 10b5-1 trading plan?

The form includes a field for plan adoption date but does not provide a date or indicate a 10b5-1 plan in the disclosed content.